# Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty

> **NCT02603900** · PHASE4 · WITHDRAWN · sponsor: **Thomas Jefferson University**

## Conditions studied

- Acute Pain
- Regional Anesthesia Morbidity

## Interventions

- **DRUG:** ropivacaine
- **DRUG:** bupivacaine
- **DEVICE:** Sham Adductor Canal Catheter
- **DEVICE:** Adductor Canal Catheter

## Key facts

- **NCT ID:** NCT02603900
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-10
- **Primary completion:** 2016-10
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02603900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02603900, "Adductor Canal Catheter vs Local Infiltration of Analgesia for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02603900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*